Tag: Israel
-
Trial: Insulin Pumps Better Control Glucose Than Injections
3 July 2014. An international clinical trial shows insulin pumps worn by people with type 2 diabetes do a better job of controlling blood glucose levels than multiple daily injections of insulin, the usual control treatment. Results from the post-marketing study funded by Medtronic Inc., a medical device developer in Minneapolis that makes insulin pumps,…
-
FDA Approves Motorized Exoskeleton for Spinal Cord Injury
27 June 2014. The Food and Drug Administration yesterday cleared for sale in the U.S. a motorized exoskeleton system for people with lower-body paralysis from spinal cord injury. The device, called ReWalk, is made by Argo Medical Technologies in Marlborough, Massachusetts, and according to FDA, the first system of its kind approved to help people…
-
FDA Approves Intermediate ALS Stem Cell Clinical Trial
28 April 2014. BrainStorm Cell Therapeutics, in New York and Israel, says the U.S. Food and Drug Administration approved its beginning an intermediate stage clinical trial of a stem cell-based therapy for amyotrophic lateral sclerosis or ALS, also known as Lou Gehrig’s disease. The trial will test for safety and tolerability of the company’s treatments…
-
Mayo Clinic Taking Part in ALS Stem Cell Clinical Trial
29 July 2014. BrainStorm Cell Therapeutics, a biotechnology company in New York and Israel says the Mayo Clinic in Rochester, Minnesota is now taking part in a clinical trial of the company’s treatments for amyotrophic lateral sclerosis (ALS) that harness the patient’s own bone marrow stem cells. Financial aspects of the agreement were not disclosed.…
-
Diabetes App Developer Files for FDA Pre-Market Clearance
LabStyle Innovations Corp. in Caesarea, Israel, developer of a mobile and cloud-based system for diabetes management, filed for pre-market notification of its system with the U.S. Food and Drug Administration. Pre-market notification, once granted by FDA, clears medical devices for marketing in the U.S. LabStyle Innovations created the Dario system that combines a small glucose…
-
Stem Cell Therapy Aids Patient with ALS, Myasthenia Gravis
BrainStorm Cell Therapeutics Inc., in New York and Israel, reports a patient with the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and myasthenia gravis responded with improved motor and cognitive functions after stem cell treatments developed by the company. Researchers from Israeli medical centers and research institutes, and the Mayo Clinic in the U.S. report the…
-
Evogene, DuPont Pioneer Extend Biotech Soybean Partnership
Evogene Ltd, a biotechnology company in Rehovot, Israel is extending its collaboration with the Pioneer subsidiary of the U.S. chemical company DuPont to develop soybean varieties resistant to Asian soybean rust, a damaging fungus to soybean plants. The agreement adds one year to the partnership between the two companies, but financial aspects of the deal…
-
Genome Analysis Via Mobile App, Web Site in Development
A genomics lab at Tel Aviv University in Israel is developing a system making it possible to upload a person’s whole genome and get results analyzed through a mobile app. Tel Aviv graduate students Ofer Isakov and Gershon Celniker in the lab of geneticist Noam Shomron are writing the software that they expect to release…
-
Engineered Castor Beans Growth-Tested as Biofuel Feedstock
The plant genomics company Evogene Ltd. in Rehovot, Israel says growing trials of its engineered castor bean show it is ready for commercial development as an alternative feedstock for biodiesel fuels and other industrial products. The three-year trials were conducted in Brazil with SLC Agrícola S.A., a grower of soybeans, corn, and cotton. Evogene’s biofuel…
-
FDA Clears Enhanced Capsule Camera for GI Disorders
The Food and Drug Administration cleared for sale in the U.S. a new version of a tiny camera in a capsule, made by Given Imaging Ltd. in Yoqneam, Israel, and swallowed by patients to diagnose gastrointestinal (GI) conditions. The company expects its PillCam SB3 to be available in the U.S. in the last quarter of…